Your Article Summary
See Latest ArticlesHydroxyethyl Starches: Different Products - Different Effects
Anesthesiology, 06/26/09
Westphal M et al. - There are clear physicochemical and pharmacokinetic differences between the generations of HES, mainly resulting from modifications to the MS and the pattern of substitution. HES should not be regarded as one homogenous group, and data for one product should not be extrapolated to another.
Related Articles
Cardiopulmonary Bypass Priming Using a High Dose of a Balanced Hydroxyethyl Starch Versus an Albumin-Based Priming Strategy
Anesthesia & Analgesia, 11/19/09
Relevance Score: 64%
Infusion of hypertonic saline/starch during cardiopulmonary bypass reduces fluid overload and may impact cardiac function
Acta Anaesthesiologica Scandinavica, 11/02/09
Relevance Score: 40%
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome
Current Medical Research and Opinion, 12/17/09
Evaluation of Anti-HBs Serum Levels and Pharmacokinetic Profile After Intravenous Administration of Niuliva, a New Hepatitis B Immunoglobulin, Following Liver Transplantation
Transplantation Proceedings, 12/17/09
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia
Leukemia and Lymphoma, 12/17/09